Arcus Biosciences Inc (RCUS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arcus Biosciences Inc   (NYSE: RCUS)


Arcus Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Arcus Biosciences Inc's ROI in the second quarter of 2026?
Arcus Biosciences Inc recorded a cumulative net loss of $-460 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -70.39%.

Within the Healthcare sector 550 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2221 to 3822.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 10.3 % 7.42 % 0.08 % -5.13 % 1.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 726 624 730 534 646
Return On Investment (TTM) -70.39 % -58.25 % -56.73 % -59.51 % -50.3 %
RCUS's Overall Ranking # 3822 # 2221 # 2917 # 2519 #
Seq. Investment Change TTM 3.16 % 1.81 % 8.6 % -3.29 % 0.47 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -460 -369 -353 -341 -298

RCUS Company Profile >> Back to RCUS Roi Comparisons >> See Annual RCUS Return On Investment



Return On Investment RCUS's Ranking
Within: No.
Industry # 245
Sector # 551
Overall # 3822

Return On Investment Statistics
High Average Low
5.98 %
-35.16 %
-75.57 %
(Sep 30 2022)   (Sep 30 2025)







Financial Statements
Arcus Biosciences Inc's II. Quarter Investments $ 726 Millions RCUS's Balance sheet
Arcus Biosciences Inc's II. Quarter Income $ -91 Millions Quarterly RCUS's Income Statement
RCUS's Income by Division See RCUS's Income by Division


RCUS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 730 533 462 657 1,426
Y / Y Investment Growth 36.96 % 15.37 % -29.68 % -53.92 % 119.15 %
Net Income in Millions -353 -283 -307 -267 53
Y / Y Net Income Growth - - - - -
Annual Return On Investment -48.36 % -53.1 % -66.45 % -40.64 % 3.71 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RCUS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RCUS's Competitors
Subscribers only: Roi for Arcus Biosciences Inc's Suppliers
Subscribers only: Return On Investment for RCUS's Customers

Other Ratios
RCUS's Roa RCUS's Inventory Turnover Ratio RCUS's Growth Rates RCUS's Dividend Statistics
RCUS's Profitability Ratios RCUS's Asset Turnover Ratio RCUS's Dividend Growth
RCUS's Roe RCUS's Valuation Ratios RCUS's Financial Strength Ratios RCUS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.